Cargando…

Can multisite clinical trial results change clinical practice? Use of long-acting injectable risperidone nationally in the Veterans Health Administration

BACKGROUND: Multisite practical clinical trials evaluate treatments in real-world practice. A multisite randomized Veterans Health Administration (VHA) cooperative study (CSP#555) published in 2011 compared the first long-acting injectable (LAI) second-generation antipsychotic (SGA), Risperidone Con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rosenheck, Robert, Anand, Sonia T., Kurtz, Stephen G., Hau, Cynthia, Smedberg, Diane, Pontzer, James F., Ferguson, Ryan E., Davis, Cynthia R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900548/ https://www.ncbi.nlm.nih.gov/pubmed/36747254 http://dx.doi.org/10.1186/s13063-023-07094-6

Ejemplares similares

Paliperidone palmitate and risperidone long-acting injectable in subjects with schizophrenia recently treated with oral risperidone or other oral antipsychotics
por: Alphs, Larry, et al.
Publicado: (2013)

Maintenance therapy with once-monthly administration of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder: a pilot study of an extended dosing interval
por: Gharabawi, Georges M, et al.
Publicado: (2007)

Modeling the Choice Between Risperidone Long-Acting Injectable and Generic Risperidone from the Perspective of a Japanese Hospital
por: Nakamura, Yusuke, et al.
Publicado: (2019)

Long-acting injectable risperidone in partially adherent and nonadherent patients with schizophrenia
por: Louzã, Mário Rodrigues, et al.
Publicado: (2011)

The cost associated with administering risperidone long-acting injections in the Australian community
por: Dalton, Andrew, et al.
Publicado: (2011)

Efficacy and safety of risperidone long-acting injection in elderly people with schizophrenia
por: Singh, Dhiren, et al.
Publicado: (2009)

Risperidone Long-Acting Injection: Safety and Efficacy in Elderly Patients with Schizophrenia
por: Catalán, Rosa, et al.
Publicado: (2011)

Management of Persistent Hyponatremia Induced by Long-acting Injectable Risperidone Therapy
por: Chowdhury, Waliul, et al.
Publicado: (2018)

Effects of Continuing Oral Risperidone vs. Switching from Risperidone to Risperidone Long-Acting Injection on Cognitive Function in Stable Schizophrenia Patients: A Pilot Study
por: Hori, Hikaru, et al.
Publicado: (2018)

Emerging treatments in the management of bipolar disorder – focus on risperidone long acting injection
por: El-Hage, Wissam, et al.
Publicado: (2010)

The effects of concurrent oral paliperidone or risperidone use with paliperidone long-acting injection
por: Stump, Trevor A., et al.
Publicado: (2021)

Long-acting risperidone injection: efficacy, safety, and cost-effectiveness of the first long-acting atypical antipsychotic
por: Chue, Pierre
Publicado: (2007)

Risperidone long-acting injection: a review of its long term safety and efficacy
por: Rainer, Michael K
Publicado: (2008)

Cumulative effects of risperidone long acting injection and narrative therapy in treating ethanol dependency
por: Trandafir, Maria Silvia
Publicado: (2010)

Patient perspectives on use of long-acting antipsychotics in bipolar disorder: focus on risperidone injection
por: Samalin, L, et al.
Publicado: (2010)

Combination treatment with risperidone long-acting injection and psychoeducational approaches for preventing relapse in schizophrenia
por: Zhao, Yueren, et al.
Publicado: (2013)

Switching from risperidone long-acting injectable to paliperidone long-acting injectable or oral antipsychotics: analysis of a Medicaid claims database
por: Voss, Erica A., et al.
Publicado: (2015)

Social determinants of mental health care systems: intensive community based Care in the Veterans Health Administration
por: Bhalla, Ish P., et al.
Publicado: (2020)

Efficacy and Safety Profile of Risperidone Long-acting Injection in Adolescents in a Real-life Setting
por: Ardic, Ulku Akyol, et al.
Publicado: (2018)

Population Pharmacokinetic Modeling and Simulation of TV‐46000: A Long‐Acting Injectable Formulation of Risperidone
por: Perlstein, Itay, et al.
Publicado: (2022)

Resources to assist in the transition to a single IRB model for multisite clinical trials
por: Hahn, Cynthia, et al.
Publicado: (2019)

Effectiveness of injectable risperidone long-acting therapy for schizophrenia: data from the US, Spain, Australia, and Belgium
por: Lambert, Tim, et al.
Publicado: (2011)

Hospitalisation Utilisation and Costs in Schizophrenia Patients in Finland before and after Initiation of Risperidone Long-Acting Injection
por: Asseburg, Christian, et al.
Publicado: (2012)

Successful Treatment of Anorexia Nervosa in a 10-year-old Boy with Risperidone Long-acting Injection
por: Umehara, Hidehiro, et al.
Publicado: (2014)

Use of therapeutic drug monitoring of risperidone microspheres long-acting injection in hemodialysis: A case report
por: Tourtellotte, Rebecca, et al.
Publicado: (2019)

Treatment of Schizophrenia With Long-Acting Fluphenazine, Haloperidol, or Risperidone
por: Olfson, Mark, et al.
Publicado: (2007)

Epidemiology of Coccidioidomycosis in the Veterans Health Administration, 2013–2022
por: Lucero-Obusan, Cynthia, et al.
Publicado: (2023)

Poly(Lactic Acid) Block Copolymers with Poly(Hexylene Succinate) as Microparticles for Long-Acting Injectables of Risperidone Drug
por: Chrysafi, Iouliana, et al.
Publicado: (2022)

Paliperidone Palmitate versus Risperidone Long-Acting Injectable in Patients with Schizophrenia: A Meta-Analysis of Efficacy and Safety
por: Zhao, Mingjun, et al.
Publicado: (2023)

Acute Hepatitis A Infection and Vaccination in the Veterans Health Administration
por: Oda, Gina, et al.
Publicado: (2019)

Clinical outcomes of long-acting injectable risperidone in patients with schizophrenia: six-month follow-up from the Electronic Schizophrenia Treatment Adherence Registry in Latin America
por: Apiquian, Rogelio, et al.
Publicado: (2011)

Zika virus infection in the Veterans Health Administration (VHA), 2015-2016
por: Schirmer, Patricia L., et al.
Publicado: (2018)

Treatment-completion rates with olanzapine long-acting injection versus risperidone long-acting injection in a 12-month, open-label treatment of schizophrenia: indirect, exploratory comparisons
por: Ascher-Svanum, Haya, et al.
Publicado: (2012)

1797. Pneumococcal Vaccination in Veterans 65 years and older with Pneumococcus in the Veterans Health Administration (VHA) since November 2021
por: Schirmer, Patricia, et al.
Publicado: (2023)

Carbon Monoxide Poisoning in the Veterans Health Administration, 2010 - 2016
por: Oda, Gina, et al.
Publicado: (2017)

1201. Diphtheria in Veterans Health Administration (VHA), 2000-2021
por: Schirmer, Patricia, et al.
Publicado: (2021)

Risperidone long-acting injection in Schizophrenia Spectrum Illnesses compared to first generation depot antipsychotics in an outpatient setting in Canada
por: Lammers, Laura, et al.
Publicado: (2013)

Medication adherence in patients with psychotic disorders: an observational survey involving patients before they switch to long-acting injectable risperidone
por: Baylé, Franck Jean, et al.
Publicado: (2015)

Bipolar Patients and Bullous Pemphigoid after Risperidone Long-Acting Injectable: A Case Report and a Review of the Literature
por: Fabrazzo, Michele, et al.
Publicado: (2021)

Clinical utility of the risperidone formulations in the management of schizophrenia
por: Madaan, Vishal, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_kbsgvs4ar8a1gh2kukdokbk6eg